# TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer

> **NCT00399750** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 373 (—)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** oxaliplatin
- **DRUG:** fluoropyrimidine
- **DRUG:** bevacizumab

## Key facts

- **NCT ID:** NCT00399750
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** —
- **Final completion:** 2005-06
- **Target enrollment:** 373 (—)
- **Last updated:** 2009-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00399750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00399750, "TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00399750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*